Filing Details

Accession Number:
0001558370-22-007835
Form Type:
13D Filing
Publication Date:
2022-05-08 20:00:00
Filed By:
Sanford Glenn Darrel
Company:
Exp World Holdings Inc. (NASDAQ:EXPI)
Filing Date:
2022-05-09
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Eugene Frederick 267,676 44,111,212 267,676 44,378,888 29.5%
Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D/A

Under the Securities Exchange Act of 1934

(Amendment No. 5)*

A picture containing text, sign, clipart  Description automatically generated

EXP WORLD HOLDINGS, INC.

(Name of Issuer)

Common Stock, $0.00001 Par Value

(Title of Class of Securities)

30212W100

(CUSIP Number)

Glenn Sanford

Penny Sanford

Jason Gesing

336 36th Street

Eugene Frederick

Bellingham, WA 98225

2219 Rimland Drive, Suite 301

Tel: (360) 393-1853

Bellingham, WA 98226

Tel (360) 685-4206

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

Copy to: ChristopherJ.Voss K&L Gates LLP

925 Fourth Avenue, Suite 2900

Seattle, Washington 98104

Tel: (206) 370-7609

March 31, 2022

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d -1(e), 240.13d -1(f) or 240.13d -1(g), check the following box [ ].

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

*Theremainderofthiscoverpageshallbefilledoutforareportingperson’sinitialfilingonthisformwithrespecttothesubjectclassofsecurities, and for any subsequent amendment containing information which would alter disclosures provided in a prior coverpage.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Act”), or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D/A

CUSIP No. 30212W100

1

NAMES OF REPORTING PERSONS

Glenn D. Sanford

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)
[X]
(b)
[]

3

SEC USE ONLY

4

SOURCE OF FUNDS (See Instructions)

Not Applicable

5

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

[ ]

6

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

7

SOLE VOTING POWER

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON

WITH

44,111,212 shares of common stock (1)

8

SHARED VOTING POWER

267,676 shares of common stock(2)

9

SOLE DISPOSITIVE POWER

44,111,212 shares of common stock(1)

10

SHARED DISPOSITIVE POWER

267,676 shares of common stock(2)

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

44,378,888 shares of common stock

12

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

[ ]

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

29.5%(3)

14

TYPE OF REPORTING PERSON (See Instructions)

IN

(1)Includes42,034,338 sharesofcommonstockandstockoptionsexercisable for an aggregate of 2,076,874sharesofcommonstock.
(2)Shares held by other members of Glenn D. Sanford’s household.
(3)Based on 150,416,865 shares of common stock issued and outstanding as of March 31, 2022.

SCHEDULE 13D/A

CUSIP No. 30212W100

1

NAMES OF REPORTING PERSONS

Penny Sanford

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)
[X]
(b)
[ ]

3

SEC USE ONLY

4

SOURCE OF FUNDS (See Instructions)

Not Applicable

5

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

[ ]

6

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

7

SOLE VOTING POWER

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON

WITH

27,764,043 shares of common stock

8

SHARED VOTING POWER

0

9

SOLE DISPOSITIVE POWER

27,764,043 shares of common stock

10

SHARED DISPOSITIVE POWER

0

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

27,764,043 shares of common stock

12

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

[ ]

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

18.5%(1)

14

TYPE OF REPORTING PERSON (See Instructions)

IN

(1)Based on 150,416,865 shares of common stock issued and outstanding as of March 31, 2022.

SCHEDULE 13D/A

CUSIP No. 30212W100

1

NAMES OF REPORTING PERSONS

Jason Gesing

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)
[X]
(b)
[ ]

3

SEC USE ONLY

4

SOURCE OF FUNDS (See Instructions)

Not Applicable

5

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

[ ]

6

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

7

SOLE VOTING POWER

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON

WITH

2,477,312 shares of common stock(1)

8

SHARED VOTING POWER

0

9

SOLE DISPOSITIVE POWER

2,477,312 shares of common stock(1)

10

SHARED DISPOSITIVE POWER

0

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,477,312 shares of common stock

12

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

[ ]

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

1.7%(2)

14

TYPE OF REPORTING PERSON (See Instructions)

IN

(1) Includes 2,177,312 sharesofcommonstockandstockoptionsexercisable for an aggregate of 300,000sharesofcommonstock.

(2) Based on 150,416,865 shares of common stock issued and outstanding as of March 31, 2022.

SCHEDULE 13D/A

CUSIP No. 30212W100

1

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Eugene Frederick

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)
[X]
(b)
[ ]

3

SEC USE ONLY

4

SOURCE OF FUNDS (See Instructions)

Not Applicable

5

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

[ ]

6

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

7

SOLE VOTING POWER

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON

WITH

5,235,254 shares of common stock(1)

8

SHARED VOTING POWER

22,771 shares of common stock(2)

9

SOLE DISPOSITIVE POWER

5,235,254 shares of common stock(1)

10

SHARED DISPOSITIVE POWER

22,771 shares of common stock (2)

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

5,258,025 shares of common stock

12

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

[ ]

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

3.5%(2)

14

TYPE OF REPORTING PERSON (See Instructions)

IN

(1) Includes 5,235,159 sharesofcommonstockandstockoptionsexercisable for an aggregate of 95 sharesofcommonstock.

(2) Shares held by other members of Eugene Frederick’s household.

(3) Based on 150,416,865 shares of common stock issued and outstanding as of March 31, 2022.

Explanatory Note

This Amendment No. 5 to Schedule 13D (“Amendment No. 5”) amends and supplements the statement on Schedule 13D filed with the Securities and Exchange Commission on June 11, 2017 as amended by that certain Amendment No. 1 to Schedule 13D filed on March 8, 2021 (“Amendment No. 1”), as further amended by that certain Amendment No. 2 to Schedule 13D filed on April 23, 2021, as further amended by that certain Amendment No. 3 to Schedule 13D filed on August 24, 2021, and as further amended by that certain Amendment No. 4 to Schedule 13D filed on January 25, 2022 (as amended, the “Schedule 13D”). This Amendment No. 5 is being filed to reflect subsequent acquisitions and dispositions of shares of Common Stock by Mr. Sanford, Mr. Gesing, Mr. Frederick, Ms. Sanford and their reported households, including dispositions pursuant to their respective 10b5-1 Sale Plans. Information reported in the Schedule 13D remains in effect except to the extent that it is amended, restated or superseded by information contained in this Amendment No. 5.  Capitalized terms used herein and not otherwise defined in this Amendment No. 5 have the meanings set forth in the Schedule 13D.

Item 5. Interest in Securities of the Issuer

(a)SeeItems11and13ofthecoverpagestothisSchedule13DfortheaggregatenumberofsharesofCommonSharesandpercentageofCommon Shares beneficially owned by each of the ReportingPersons.

As of March 31, 2022, the Reporting Persons as a group are the beneficial owners of 79,878,268 shares of Common Stock. Such shares of Common Stock represent beneficial ownership of 53.2% of outstanding shares of Common Stock.

By virtue of the relationship described in Amendment No. 1, the Reporting Persons may be deemed to constitute a “group” within the meaning of Rule 13d-5 under the Act. As a member of a group, each Reporting Person may be deemed to share voting and dispositive power with respect to, and therefore beneficially own, the securities of the Company beneficially owned by members of the group as a whole. The filing of this Statement shall not be construed as an admission that the Reporting Persons beneficially own those securities held by another member of such group. In addition, each Reporting Person expressly disclaims beneficial ownership of any securities reported herein except to the extent such Reporting Person actually exercises voting or dispositive power with respect to such securities.

(a)See items 7 through 10 of the cover pages to this Schedule 13D for the number of shares of Common Stock beneficially owned by each of the Reporting Persons as to which there is sole power to vote or to direct the vote, shared power to vote or to direct the vote and sole or shared power to dispose or to direct thedisposition.
(b)Schedule A hereto sets forth certain information with respect to transactions by the Reporting Persons in shares of Common Stock during the past 60days.
(c)ExceptassetforthinthisSchedule13D,totheknowledgeoftheReportingPersons,nopersonhastherighttoreceiveorthepowertodirectthe receipt of dividends from, or the proceeds from the sale of, securities covered by this Schedule13D.

(d)Not applicable.

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: May 9, 2022

/s/ GlennSanford

Glenn Sanford

Dated: May 9, 2022

/s/ PennySanford

Penny Sanford

Dated: May 9, 2022

/s/ Jason Gesing

Jason Gesing

Dated: May 9, 2022

/s/ Eugene Frederick

Eugene Frederick

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).

SCHEDULE A

Transactions in Shares of Common Stock in the last 60 days

Nature of the Transaction

 

Amount of Shares

Purchased/(Sold)

 

Price ($)

 

Date of

Purchase/Sale

 

Glenn Sanford

Acquisition of Non-Derivative Securities

15,866

0.07

05/03/2022

Sale of Common Stock1

(15,866)

15.01642

05/03/2022

Acquisition of Non-Derivative Securities

46,525

0.07

05/04/2022

Sale of Common Stock3

(45,725)

15.45424

05/04/2022

Sale of Common Stock5

(800)

16.18386

05/04/2022

Exercise of Derivative Securities

(15,966)

0.00

05/03/2022

Exercise of Derivative Securities

(46,525)

0.00

05/04/2022

Acquisition of Non-Derivative Securities

100

0.07

04/26/2022

Sale of Common Stock7

(100)

15.10

04/26/2022

Acquisition of Non-Derivative Securities

509

0.07

04/27/2022

Sale of Common Stock8

(509)

15.01739

04/27/2022

Exercise of Derivative Securities

(100)

0.00

04/26/2022

Exercise of Derivative Securities

(509)

0.00

04/27/2022

Acquisition of Non-Derivative Securities

3,456

0.07

04/22/2022

Sale of Common Stock10

(3,456)

15.440911

04/22/2022

Acquisition of Non-Derivative Securities

14,544

0.07

04/25/2022

1 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

3 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

4 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

5 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

6 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.08 to $16.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

7 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

8 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

9 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.095, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

10 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

11 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.04 to $15.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Sale of Common Stock12

(14,544)

15.310713

04/25/2022

Exercise of Derivative Securities

(3,456)

0.00

04/22/2022

Exercise of Derivative Securities

(14,544)

0.00

04/25/2022

Acquisition of Non-Derivative Securities

9,000

0.07

04/20/2022

Sale of Common Stock14

(9,000)

16.480815

04/20/2022

Acquisition of Non-Derivative Securities

9,000

0.07

04/21/2022

Sale of Common Stock16

(7,220)

15.589717

04/21/2022

Sale of Common Stock18

(1,780)

16.655219

04/21/2022

Exercise of Derivative Securities

(9,000)

0.00

04/20/2022

Exercise of Derivative Securities

(9,000)

0.00

04/21/2022

Acquisition of Non-Derivative Securities

9,000

0.07

04/18/2022

Sale of Common Stock20

(9,000)

15.886721

04/18/2022

Acquisition of Non-Derivative Securities

9,000

0.07

04/19/2022

Sale of Common Stock22

(9,000)

16.506523

04/19/2022

Exercise of Derivative Securities

(9,000)

0.00

04/18/2022

Exercise of Derivative Securities

(9,000)

0.00

04/19/2022

Acquisition of Non-Derivative Securities

9,000

0.07

04/13/2022

12 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

13 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

14 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

15 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

16 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

17 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.22 to $16.21, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

18 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

19 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.22 to $17.21, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

20 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

21 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.49 to $16.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

22 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

23 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.87 to $16.83, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Sale of Common Stock24

(9,000)

17.035425

04/13/2022

Acquisition of Non-Derivative Securities

9,000

0.07

04/14/2022

Sale of Common Stock26

(8,971)

16.689927

04/14/2022

Sale of Common Stock28

(29)

17.30

04/14/2022

Exercise of Derivative Securities

(9,000)

0.00

04/13/2022

Exercise of Derivative Securities

(9,000)

0.00

04/14/2022

Acquisition of Non-Derivative Securities

9,000

0.07

04/11/2022

Sale of Common Stock29

(8,800)

17.071930

04/11/2022

Sale of Common Stock31

(200)

17.4032

04/11/2022

Acquisition of Non-Derivative Securities

9,000

0.07

04/12/2022

Sale of Common Stock33

(8,173)

17.079534

04/12/2022

Sale of Common Stock35

(827)

17.768336

04/12/2022

Exercise of Derivative Securities

(9,000)

0.00

04/11/2022

Exercise of Derivative Securities

(9,000)

0.00

04/12/2022

Acquisition of Non-Derivative Securities

9,000

0.07

04/07/2022

Sale of Common Stock37

(7,200)

17.295238

04/07/2022

24 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

25 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.53 to $17.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

26 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

27 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.29 to $17.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

28 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

29 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

30 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.37 to $17.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

31 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

32 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.39 to $17.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

33 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

34 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.62 to $17.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

35 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

36 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.62 to $17.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

37 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

38 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.92 to $17.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Sale of Common Stock39

(1,800)

18.6640

04/07/2022

Acquisition of Non-Derivative Securities

9,000

0.07

04/08/2022

Sale of Common Stock41

(9,000)

16.792942

04/08/2022

Exercise of Derivative Securities

(9,000)

0.00

04/07/2022

Exercise of Derivative Securities

(9,000)

0.00

04/08/2022

Acquisition of Non-Derivative Securities

9,000

0.07

04/05/2022

Sale of Common Stock43

(7,700)

20.11944

04/05/2022

Sale of Common Stock45

(1,200)

21.1746

04/05/2022

Sale of Common Stock47

(100)

21.77

04/05/2022

Acquisition of Non-Derivative Securities

9,000

0.07

04/06/2022

Sale of Common Stock48

(8,925)

18.715749

04/06/2022

Sale of Common Stock50

(75)

19.49

04/06/2022

Exercise of Derivative Securities

(9,000)

0.00

04/05/2022

Exercise of Derivative Securities

(9,000)

0.00

04/06/2022

Acquisition of Non-Derivative Securities

9,000

0.07

04/01/2022

Sale of Common Stock51

(8,500)

20.500752

04/01/2022

39 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

40 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.39 to $19.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

41 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

42 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.24 to $17.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

43 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

44 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.73 to $20.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

45 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

46 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.74 to $21.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

47 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

48 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

49 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.48 to $19.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

50 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

51 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

52 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.10 to $21.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Sale of Common Stock53

(500)

21.28654

04/01/2022

Acquisition of Non-Derivative Securities

9,000

0.07

04/04/2022

Sale of Common Stock55

(2,982)

21.522156

04/04/2022

Sale of Common Stock57

(6,018)

22.036458

04/04/2022

Exercise of Derivative Securities

(9,000)

0.00

04/01/2022

Exercise of Derivative Securities

(9,000)

0.00

04/04/2022

Acquisition of Non-Derivative Securities

9,000

0.07

03/30/2022

Sale of Common Stock59

(5,344)

22.677860

03/30/2022

Sale of Common Stock61

(3,656)

23.472662

03/30/2022

Acquisition of Non-Derivative Securities

9,000

0.07

03/31/2022

Sale of Common Stock63

(8,500)

21.62864

03/31/2022

Sale of Common Stock65

(500)

22.18466

03/31/2022

Exercise of Derivative Securities

(9,000)

0.00

03/30/2022

Exercise of Derivative Securities

(9,000)

0.00

03/31/2022

Acquisition of Non-Derivative Securities

9,000

0.07

03/28/2022

53 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

54 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.19 to $21.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

55 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

56 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.75 to $21.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

57 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

58 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.75 to $22.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

59 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

60 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.19 to $23.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

61 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

62 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.19 to $23.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

63 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

64 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.12 to $22.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

65 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

66 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.13 to $22.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Sale of Common Stock67

(7,861)

21.601368

03/28/2022

Sale of Common Stock69

(1,139)

22.230870

03/28/2022

Acquisition of Non-Derivative Securities

9,000

0.07

03/29/2022

Sale of Common Stock71

(4,744)

23.265572

03/29/2022

Sale of Common Stock73

(4,256)

23.669574

03/29/2022

Exercise of Derivative Securities

(9,000)

0.00

03/28/2022

Exercise of Derivative Securities

(9,000)

0.00

03/29/2022

Acquisition of Non-Derivative Securities

9,000

0.07

03/24/2022

Sale of Common Stock75

(8,900)

23.613776

03/24/2022

Sale of Common Stock77

(100)

24.10

03/24/2022

Acquisition of Non-Derivative Securities

9,000

0.07

03/25/2022

Sale of Common Stock78

(6,455)

22.079379

03/25/2022

Sale of Common Stock80

(2,145)

23.140681

03/25/2022

Sale of Common Stock82

(400)

23.788883

03/25/2022

Exercise of Derivative Securities

(9,000)

0.00

03/24/2022

67 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

68 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.15 to $22.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

69 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

70 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.15 to $22.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

71 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

72 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.50 to $23.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

73 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

74 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.50 to $23.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

75 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

76 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.07 to $23.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

77 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

78 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

79 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.65 to $22.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

80 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

81 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.70 to 23.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

82 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

83 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.72 to 23.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Exercise of Derivative Securities

(9,000)

0.00

03/25/2022

Acquisition of Non-Derivative Securities

9,000

0.07

03/22/2022

Sale of Common Stock84

(8,567)

25.29985

03/22/2022

Sale of Common Stock86

(433)

25.6687

03/22/2022

Acquisition of Non-Derivative Securities

9,000

0.07

03/23/2022

Sale of Common Stock88

(7,055)

24.396189

03/23/2022

Sale of Common Stock90

(1,945)

25.258491

03/23/2022

Exercise of Derivative Securities

(9,000)

0.00

03/22/2022

Exercise of Derivative Securities

(9,000)

0.00

03/23/2022

Acquisition of Non-Derivative Securities

9,000

0.07

03/18/2022

Sale of Common Stock92

(7,588)

25.387393

03/18/2022

Sale of Common Stock94

(1,412)

26.093595

03/18/2022

Acquisition of Non-Derivative Securities

9,000

0.07

03/21/2022

Sale of Common Stock96

(8,626)

24.60197

03/21/2022

Sale of Common Stock98

(374)

25.463299

03/21/2022

84 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

85 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.61 to $25.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

86 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

87 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.62 to $25.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

88 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

89 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

90 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

91 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.04 to $25.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

92 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

93 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.91 to $25.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

94 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

95 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.91 to $26.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

96 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

97 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.21 to $25.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

98 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

99 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.26 to $25.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Exercise of Derivative Securities

(9,000)

0.00

03/18/2022

Exercise of Derivative Securities

(9,000)

0.00

03/21/2022

Acquisition of Non-Derivative Securities

9,000

0.07

03/16/2022

Sale of Common Stock100

(6,961)

24.7107101

03/16/2022

Sale of Common Stock102

(2,039)

25.0456103

03/16/2022

Acquisition of Non-Derivative Securities

9,000

0.07

03/17/2022

Sale of Common Stock104

(8,411)

25.3307105

03/17/2022

Sale of Common Stock106

(589)

25.9077107

03/17/2022

Exercise of Derivative Securities

(9,000)

0.00

03/16/2022

Exercise of Derivative Securities

(9,000)

0.00

03/17/2022

Acquisition of Non-Derivative Securities

9,000

0.07

03/14/2022

Sale of Common Stock108

(4,908)

21.21109

03/14/2022

Sale of Common Stock110

(4,092)

22.5987111

03/14/2022

Acquisition of Non-Derivative Securities

9,000

0.07

03/15/2022

Sale of Common Stock112

(2,642)

21.81113

03/15/2022

100 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

101 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.99 to $24.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

102 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

103 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.99 to $25.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

104 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

105 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.62 to $25.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

106 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

107 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.64 to $26.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

108 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

109 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.21 to $22.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

110 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

111 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.21 to $23.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

112 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

113 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.24 to $22.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Sale of Common Stock114

(6,058)

22.7477115

03/15/2022

Sale of Common Stock116

(300)

23.255117

03/15/2022

Exercise of Derivative Securities

(9,000)

0.00

03/14/2022

Exercise of Derivative Securities

(9,000)

0.00

03/15/2022

Acquisition of Non-Derivative Securities

9,000

0.07

03/10/2022

Sale of Common Stock118

(9,000)

23.8002119

03/10/2022

Acquisition of Non-Derivative Securities

9,000

0.07

03/11/2022

Sale of Common Stock120

(7,348)

23.0754121

03/11/2022

Sale of Common Stock122

(1,652)

24.0414123

03/11/2022

Exercise of Derivative Securities

(9,000)

0.00

03/10/2022

Exercise of Derivative Securities

(9,000)

0.00

03/11/2022

Acquisition of Non-Derivative Securities

9,000

0.07

03/08/2022

Sale of Common Stock124

(8,000)

22.9005125

03/08/2022

Sale of Common Stock126

(1,000)

23.569127

03/08/2022

Acquisition of Non-Derivative Securities

9,000

0.07

03/09/2022

114 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

115 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.25 to $23.245, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

116 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

117 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.25 to $23.265, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

118 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

119 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.39 to $24.21, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

120 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

121 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.77 to $23.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

122 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

123 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.84 to $24.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

124 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

125 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.32 to $23.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

126 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

127 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.33 to $23.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Sale of Common Stock128

(9,000)

24.2474129

03/09/2022

Exercise of Derivative Securities

(9,000)

0.00

03/08/2022

Exercise of Derivative Securities

(9,000)

0.00

03/09/2022

Acquisition of Non-Derivative Securities

9,000

0.07

03/07/2022

Sale of Common Stock130

(6,042)

23.1681131

03/07/2022

Sale of Common Stock132

(2,658)

24.0656133

03/07/2022

Sale of Common Stock134

(300)

24.8267135

03/07/2022

Exercise of Derivative Securities

(9,000)

0.00

03/07/2022

Penny Sanford

Sale of Common Stock136

(10,649)

25.0431137

03/16/2022

Sale of Common Stock138

(28,951)

25.4145139

03/17/2022

Sale of Common Stock140

(400)

26.065141

03/17/2022

Jason Gesing

Sale of Common Stock142

(7,000)

13.3007143

05/02/2022

128 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

129 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.57 to $24.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

130 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

131 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.76 to $23.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

132 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

133 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.77 to $24.635, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

134 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

135 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.77 to $24.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

136 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

137 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

138 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

139 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

140 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

141 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.06 to $26.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

142 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

143 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.16 to $13.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Acquisition of Non-Derivative Securities

25,000

0.08

04/13/2022

Exercise of Derivative Securities

(25,000)

0.00

04/13/2022

Acquisition of Non-Derivative Securities

25,000

0.08

03/23/2022

Exercise of Derivative Securities

(25,000)

0.00

03/23/2022

Eugene Frederick

Restricted Stock Units issued under the Issuer’s Real Estate Agent Growth Incentive Program144/145

38

0.00

04/30/2022

Common Stock issued as Director Compensation146

150

0.00

04/30/2022

Restricted Stock Units issued under the Issuer’s Real Estate Agent Growth Incentive Program147/148

7

0.00

04/30/2022

Restricted Stock Units issued under the Issuer’s Real Estate Agent Growth Incentive Program149/150

15

0.00

03/31/2022

Common Stock issued as Director Compensation151

95

0.00

03/31/2022

Restricted Stock Units issued under the Issuer’s Real Estate Agent Growth Incentive Program152/153

38

0.00

03/31/2022

144 Includes unvested restricted stock units.

145 Represents Restricted Stock Units issued under the Issuer’s Real Estate Agent Growth Incentive Program. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer’s Common Stock and vests three years after the date of grant.

146These shares were issued to the reporting person as compensation for his services as a director.

147 Includes unvested restricted stock units.

148 Represents Restricted Stock Units issued under the Issuer’s Real Estate Agent Growth Incentive Program. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer’s Common Stock and vests three years after the date of grant.

149 Includes unvested restricted stock units.

150 Represents Restricted Stock Units issued under the Issuer’s Real Estate Agent Growth Incentive Program. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer’s Common Stock and vests three years after the date of grant.

151These shares were issued to the reporting person as compensation for his services as a director.

152 Includes unvested restricted stock units.

153 Represents Restricted Stock Units issued under the Issuer’s Real Estate Agent Growth Incentive Program. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer’s Common Stock and vests three years after the date of grant.